Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Controlled dermal DNAzyme delivery via chitosan hydrogels
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: EICHER, Anna-Carola (University of Applied Sciences Mittelhessen, Life Science Engineering, Giessen, Germany)
- Co-author(s): Anna-Carola Eicher: Life Science Engineering, Institute of Bioprocess Engineering and Pharmaceutical Technology, Giessen, Germany
Sebastian Beer: Life Science Engineering, University of Applied Sciences Mittelhessen, Giessen, Germany;Life Science Engineering, Inst
BackgroundsThe dermal application of DNA based active pharmaceutical ingredients (API) requires a protective drug delivery system due to the incidence of degrading enzymes on the skin surface.
The aim of this study is the development of a chitosan hydrogel for the protection of the API and its controlled release.
A promising approach is the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019